Changes in ADMA and TAFI levels after stenting in coronary artery disease patients

Author： Khalifa Nouran M.   Gad Mohamed Z.   Hataba Alaa A.   Mahran Laila G.  

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.6, Iss.4, 2012-10, pp. : 855-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A metaanalysis of randomized controlled trials

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 3, 2013-01 ,pp. : 819-825

Spandidos Publications

Access to resources Recommend Favorite

Correlation between serum high-mobility group box1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 121-124

Spandidos Publications

Access to resources Recommend Favorite

APJ polymorphisms in coronary artery disease patients with and without hypertension

By                

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 321-325

Spandidos Publications

Access to resources Recommend Favorite

Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease

By  

Experimental and Therapeutic Medicine, Vol. 8, Iss. 6, 2014-01 ,pp. : 1951-1957

Spandidos Publications

Access to resources Recommend Favorite

Association between red cell distribution width and the risk of heart events in patients with coronary artery disease

By                              

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1508-1514

Spandidos Publications

Access to resources Recommend Favorite